Mild Cognitive Impairment, Alzheimer's disease research hub

A PHASE 1B DOSE RANGE FINDING STUDY OF PHENSERINE COMPARED TO DONEPEZIL IN PARTICIPANTS WITH EARLY OR MILD ALZHEIMER’S DISEASE

This study is looking at a new drug called phenserine for people with early or mild Alzheimer's disease. Researchers want to see how different doses of phenserine affect changes in the brain, and compare it to a common Alzheimer's drug called donepezil.